S. Schäfer

Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced Melanoma

J. Hassel, D. Machiraju, S. Schäfer, 2021, Life.

Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling

Christian Ruckert, Martin Götte, Burkhard Greve, 2014, Molecular Cancer.

Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancer.

L. Kiesel, J. Blohmer, Christof Bernemann, 2019, Future oncology.

Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma

J. Hassel, P. Beckhove, D. Machiraju, 2023, Frontiers in Medicine.

The predictive value of preoperative frailty screening for postoperative outcomes in older patients undergoing surgery for non-metastatic colorectal cancer.

P. van Duijvendijk, H. J. van der Zaag-Loonen, T. Argillander, 2022, Journal of geriatric oncology.